CompositionPAI Standard S1 (human), lyophilized: 0.0 U/mL PAIPAI Standard S2 (human), lyophilized: 5 to 7 U/mL PAI (exact concentration information: see vial lable)PAI Control Plasma (human), lyophilized: 2.5 to 4.0 U/mL PAIUrokinase Reagent, lyophilized; concentration in the working solution: 5 IU/mL urokinase (human), Tris (100 mmol/L), pH8.4Plasminogen Reagent: lyophilized; concentration in the working solution: 15 CTA U/mL plasminogen (human), Tris (100 mmol/L), pH8.4Oxidant, lyophilize; chloramines T, concentration in the working solution: 1.8 g/LPlasmin Substrate, lyophilized; concentration in the working solution: HD-Norvaly-cyclohexyl-ananyl-lysyl-p-nitroanilide (HD-Nva-CHA-Lys-pNA) 0.6 mmol/LSubstrate Working Solution; NaCl (35 g/L), Tris (50 mmol/L), pH 8.4
共有 1 個藥物證書使用此成份
- 申請商
- 台灣希森美康股份有限公司
- 適應症
- 含量
- 發證日期
- 2005-09-08